At a glance
- Originator LEK
- Class Analgesics; Beta-Cyclodextrins; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 08 Jul 1998 Discontinued-Preclinical for Pain in Slovenia (Unknown route)
- 17 Jan 1997 Preclinical development for Pain in Slovenia (Unknown route)